Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

Sponsor
StemCyte Taiwan Co., Ltd.
Study ID
NCT06377982
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cerebral Palsy

Eligibility Criteria

Sex
ALL
Age
1 Year - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • hUCB — BIOLOGICAL
    hUCB

Study Details

A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy

Key Dates

First listed
Apr 22, 2024
Start date
Sep 30, 2025
Status verified
Feb 2025
Primary completion
Sep 30, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
12 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: hUCB treatment
    Human cord blood infusion
  • No Intervention: Placebo treatment
    Placebo infusion

Primary Outcome Measure

safety-TEAE [ Time Frame: From screening to 56 weeks ]

Central Contacts

Related Studies